University of California San Francisco

TommasoPollini-144x192
Tommaso Pollini, MD

Postdoctoral Research Fellow

[email protected]

Biography

Dr. Tommaso Pollini, M.D. is a post-doctoral research fellow at the University of California, San Francisco (UCSF) in the Maker Lab, specializing in pancreatic cystic neoplasms with a focus on Intraductal Papillary Mucinous Neoplasms (IPMN). He completed his surgical training at the Pancreas Institute of the University of Verona, Italy, where he developed a solid foundation in pancreatic diseases. Recognized for his contributions to the field, Dr. Pollini received the prestigious Kenneth Warren Fellowship from the International Hepato-Pancreato-Biliary Association and the Steve Sotsky Award from the American Hepato-Pancreato-Biliary Association.

At UCSF, his research centers on developing predictive models for high-grade dysplasia in pancreatic cystic tumors using machine learning. Utilizing his expertise in bioinformatics, single-nucleus RNA sequencing (snRNAseq), and spatial transcriptomics, he studies the tumor immune microenvironment of pancreatic cancers. Dr. Pollini has published his work in leading journals such as JAMA Surgery, The Lancet Gastroenterology & Hepatology, and Gastroenterology, contributing significantly to advancements in pancreatic cancer research.

Education

Institution Degree Dept or School End Date
University of Verona General Surgery Residency 01/2023
University of Verona Research Fellow at the Department of General and Pancreatic Surgery of the Pancreas Institute 12/2017
University of Verona MD Medicine 10/2015

Awards & Honors

Award Conferred By Date
Kenneth Warren Fellowship International Hepato-Pancreato-Biliary Association (IHPBA) 2021/2022
Steve Sotksi Award American Hepato-Pancreato-Biliary Association (AHPBA) 2021

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 38
  1. The Actual Prevalence of Symptoms in Pancreatic Cystic Neoplasms: A Prospective Propensity Matched Cohort Analysis.
    Marchegiani G, Andrianello S, Miatello C, Pollini T, Secchettin E, Tedesco G, D'Onofrio M, Malleo G, Bassi C, Salvia R| | PubMed
  2. Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases.
    Paiella S, De Pastena M, Faustini F, Landoni L, Pollini T, Bonamini D, Giuliani T, Bassi C, Esposito A, Tuveri M, Salvia R| | PubMed
  3. The role of age in pancreatic intraductal papillary mucinous neoplasms of the pancreas: Same risk of death but different implications for management.
    Marchegiani G, Andrianello S, Perri G, Pollini T, Caravati A, Secchettin E, Malleo G, Bassi C, Salvia R| | PubMed
  4. Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results.
    Paiella S, Salvia R, De Pastena M, Pollini T, Casetti L, Landoni L, Esposito A, Marchegiani G, Malleo G, De Marchi G, Scarpa A, D'Onofrio M, De Robertis R, Pan TL, Maggino L, Andrianello S, Secchettin E, Bonamini D, Melisi D, Tuveri M, Bassi C| | PubMed
  5. Systematic review, meta-analysis, and a high-volume center experience supporting the new role of mural nodules proposed by the updated 2017 international guidelines on IPMN of the pancreas.
    Marchegiani G, Andrianello S, Borin A, Dal Borgo C, Perri G, Pollini T, Romanò G, D'Onofrio M, Gabbrielli A, Scarpa A, Malleo G, Bassi C, Salvia R| | PubMed
  6. Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity Results from a Single-Center Surgical Series.
    Paiella S, Marchegiani G, Miotto M, Malpaga A, Impellizzeri H, Montagnini G, Pollini T, Nessi C, Butturini G, Capelli P, Posenato I, Scarpa A, D'Onofrio M, De Robertis R, Cingarlini S, Boninsegna L, Bassi C, Salvia R, Landoni L| | PubMed
  7. Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center.
    Paiella S, De Pastena M, Pollini T, Zancan G, Ciprani D, De Marchi G, Landoni L, Esposito A, Casetti L, Malleo G, Marchegiani G, Tuveri M, Marrano E, Maggino L, Secchettin E, Bonamini D, Bassi C, Salvia R| | PubMed
  8. Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies.
    Andrianello S, Marchegiani G, Malleo G, Pollini T, Bonamini D, Salvia R, Bassi C, Landoni L| | PubMed
38
View all 38 Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 38
  1. Impact of coronary artery stenting on perioperative mortality and complications in patients undergoing pancreaticoduodenectomy.
    Wong P, Tran TB, Pollini T, Hernandez S, Zampese M, Todeschini L, Aguilar LL, Maker VK, Maker AV| | PubMed
  2. ASO Visual Abstract: Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma.
    Wong P, Pollini T, Adam MA, Alseidi A, Corvera CU, Hirose K, Kirkwood KS, Nakakura EK, Thornblade L, Maker AV| | PubMed
  3. ASO Author Reflections: Is Adjuvant Therapy Necessary for All Patients with Invasive Mucinous Cystic Neoplasms of the Pancreas? Let's De-escalate.
    Wong P, Pollini T, Maker AV| | PubMed
  4. Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma.
    Wong P, Pollini T, Adam MA, Alseidi A, Corvera CU, Hirose K, Kirkwood KS, Nakakura EK, Thornblade L, Maker AV| | PubMed
  5. Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: a competing risk analysis.
    Crippa S, Marchegiani G, Belfiori G, Rancoita PVM, Pollini T, Burelli A, Apadula L, Scarale MG, Socci D, Biancotto M, Vanella G, Arcidiacono PG, Capurso G, Salvia R, Falconi M| | PubMed
  6. Pancreas Cyst Diagnosis and Advances in Cyst Fluid Analysis.
    Pollini T, Todeschini L, Maker AV| | PubMed
  7. Reply.
    Casciani F, Pollini T, Salvia R| | PubMed
  8. Intraoperative hepatic artery infusion pump perfusion testing with indocyanine green near-infrared imaging offers multiple potential advantages.
    Wong P, Hoffman D, Pollini T, Zampese M, Corvera CU, Maker AV| | PubMed
  9. "Mickey Mouse sign" to identify and remove cystic duct stones in postcholecystectomy syndrome.
    O'Rear J, Wong P, Pollini T, Maker VK, Maker AV| | PubMed
  10. Improved survival of patients receiving immunotherapy and chemotherapy following curative-intent resection of colorectal liver metastases.
    Pollini T, Tran T, Wong P, Adam MA, Alseidi A, Corvera C, Hirose K, Nakakura E, Warren R, Maker VK, Maker AV| | PubMed
  11. Artificial intelligence-based models to assess the risk of malignancy on radiological imaging in patients with intraductal papillary mucinous neoplasm of the pancreas: scoping review.
    Balduzzi A, Janssen BV, De Pastena M, Pollini T, Marchegiani G, Marquering H, Stoker J, Verpalen I, Bassi C, Besselink MG, Salvia R, Pancreatobiliary and Hepatic Artificial Intelligence Research (PHAIR) consortium| | PubMed
  12. Concomitant Serous Cystadenoma and Intraductal Papillary Mucinous Neoplasm in Pancreatic Cysts-a Diagnostic and Surgical Dilemma.
    Pollini T, Salvia R, Maker AV| | PubMed
  13. Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation.
    Marchegiani G, Pollini T, Burelli A, Han Y, Jung HS, Kwon W, Rocha Castellanos DM, Crippa S, Belfiori G, Arcidiacono PG, Capurso G, Apadula L, Zaccari P, Noia JL, Gorris M, Busch O, Ponweera A, Mann K, Demir IE, Phillip V, Ahmad N, Hackert T, Heckler M, Lennon AM, Afghani E, Vallicella D, Dall'Olio T, Nepi A, Vollmer CM, Friess H, Ghaneh P, Besselink M, Falconi M, Bassi C, Goh BK, Jang JY, Fernández-Del Castillo C, Salvia R| | PubMed
  14. It is not necessary to resect all mucinous cystic neoplasms of the pancreas: current guidelines do not reflect the actual risk of malignancy.
    Pollini T, Marchegiani G, Facciorusso A, Balduzzi A, Biancotto M, Bassi C, Maker AV, Salvia R| | PubMed
  15. Drain Placement After Pancreatic Resection: Friend or Foe For Surgical Site Infections?
    Pollini T, Wong P, Kone LB, Khoury RE, Kabir C, Maker VK, Banulescu M, Maker AV| | PubMed
  16. The Landmark Series: Intraductal Papillary Mucinous Neoplasms of the Pancreas-From Prevalence to Early Cancer Detection.
    Pollini T, Wong P, Maker AV| | PubMed
  17. The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms.
    Pollini T, Adsay V, Capurso G, Dal Molin M, Esposito I, Hruban R, Luchini C, Maggino L, Matthaei H, Marchegiani G, Scarpa A, Wood LD, Bassi C, Salvia R, Mino-Kenudson M, Maker AV| | PubMed
  18. Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance.
    Marchegiani G, Andrianello S, Crippa S, Pollini T, Belfiori G, Gozzini L, Cassalia F, Caravati A, Luchini C, Doglioni C, Bassi C, Falconi M, Salvia R| | PubMed
  19. The use of a mobile application to disseminate guidelines on cystic neoplasms of the pancreas - A snapshot study of 1000 case-simulations.
    Marchegiani G, Balduzzi A, Pollini T, Caravati A, Biancotto M, Andrianello S, Zampese M, Bassi C, Salvia R| | PubMed
  20. Progression vs Cyst Stability of Branch-Duct Intraductal Papillary Mucinous Neoplasms After Observation and Surgery.
    Marchegiani G, Pollini T, Andrianello S, Tomasoni G, Biancotto M, Javed AA, Kinny-Köster B, Amini N, Han Y, Kim H, Kwon W, Kim M, Perri G, He J, Bassi C, Goh BK, Katz MH, Jang JY, Wolfgang C, Salvia R| | PubMed
  21. The faith of non-surveilled pancreatic cysts: a bicentric retrospective study.
    Surci N, Marchegiani G, Andrianello S, Pollini T, Mühlbacher J, Jomrich G, Richwien P, Tamandl D, Schindl M, Bassi C, Salvia R, Sahora K| | PubMed
  22. Systematic review and meta-analysis of observational studies on BD-IPMNS progression to malignancy.
    Balduzzi A, Marchegiani G, Pollini T, Biancotto M, Caravati A, Stigliani E, Burelli A, Bassi C, Salvia R| | PubMed
  23. Serous Cystic Neoplasms of the Pancreas Management in the Real-world: Still Operating on a Benign Entity.
    Marchegiani G, Caravati A, Andrianello S, Pollini T, Bernardi G, Biancotto M, Malleo G, Bassi C, Salvia R| | PubMed
  24. Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma.
    Simoni N, Micera R, Paiella S, Guariglia S, Zivelonghi E, Malleo G, Rossi G, Addari L, Giuliani T, Pollini T, Cavedon C, Salvia R, Milella M, Bassi C, Mazzarotto R| | PubMed
  25. Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma.
    Trestini I, Paiella S, Sandini M, Sperduti I, Elio G, Pollini T, Melisi D, Auriemma A, Soldà C, Bonaiuto C, Tregnago D, Avancini A, Secchettin E, Bonamini D, Lanza M, Pilotto S, Malleo G, Salvia R, Bovo C, Gianotti L, Bassi C, Milella M| | PubMed
  26. Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey.
    Pezzilli R, Buscarini E, Pollini T, Bonamini D, Marchegiani G, Crippa S, Belfiori G, Sperti C, Moletta L, Pozza G, De Nucci G, Manes G, Mandelli ED, Casadei R, Ricci C, Alicante S, Vattiato C, Carrara S, Di Leo M, Fabbri C, Giovanelli S, Barresi L, Tacelli M, Mirante VG, Conigliaro R, Antonini F, Macarri G, Frulloni L, De Marchi G, Sassatelli R, Cecinato P, Del Vecchio Blanco G, Galli A, Pezzullo A, Fantin A, Graffeo M, Frego M, Stillittano D, Monica F, Germanà B, Capurso G, Quartini M, Veneroni L, Cannizzaro R, Falconi M| | PubMed
  27. Branch Duct Intraductal Papillary Mucinous Neoplasms: Recommendations for Follow-Up and Surgery.
    Caravati A, Andrianello S, Pollini T, Biancotto M, Balduzzi A, Malleo G, Salvia R, Marchegiani G| | PubMed
  28. "Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation?
    Marchegiani G, Andrianello S, Pollini T, Caravati A, Biancotto M, Secchettin E, Bonamini D, Malleo G, Bassi C, Salvia R| | PubMed
  29. The management of intraductal papillary mucinous neoplasms of the pancreas.
    Pollini T, Andrianello S, Caravati A, Perri G, Malleo G, Paiella S, Marchegiani G, Salvia R| | PubMed
  30. The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution.
    Landoni L, Marchegiani G, Pollini T, Cingarlini S, D'Onofrio M, Capelli P, De Robertis R, Davì MV, Amodio A, Impellizzeri H, Malpaga A, Miotto M, Boninsegna L, Crepaz L, Nessi C, Zingaretti CC, Paiella S, Esposito A, Casetti L, Malleo G, Tuveri M, Butturini G, Salvia R, Scarpa A, Falconi M, Bassi C| | PubMed
  31. The Actual Prevalence of Symptoms in Pancreatic Cystic Neoplasms: A Prospective Propensity Matched Cohort Analysis.
    Marchegiani G, Andrianello S, Miatello C, Pollini T, Secchettin E, Tedesco G, D'Onofrio M, Malleo G, Bassi C, Salvia R| | PubMed
  32. Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases.
    Paiella S, De Pastena M, Faustini F, Landoni L, Pollini T, Bonamini D, Giuliani T, Bassi C, Esposito A, Tuveri M, Salvia R| | PubMed
  33. The role of age in pancreatic intraductal papillary mucinous neoplasms of the pancreas: Same risk of death but different implications for management.
    Marchegiani G, Andrianello S, Perri G, Pollini T, Caravati A, Secchettin E, Malleo G, Bassi C, Salvia R| | PubMed
  34. Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results.
    Paiella S, Salvia R, De Pastena M, Pollini T, Casetti L, Landoni L, Esposito A, Marchegiani G, Malleo G, De Marchi G, Scarpa A, D'Onofrio M, De Robertis R, Pan TL, Maggino L, Andrianello S, Secchettin E, Bonamini D, Melisi D, Tuveri M, Bassi C| | PubMed
  35. Systematic review, meta-analysis, and a high-volume center experience supporting the new role of mural nodules proposed by the updated 2017 international guidelines on IPMN of the pancreas.
    Marchegiani G, Andrianello S, Borin A, Dal Borgo C, Perri G, Pollini T, Romanò G, D'Onofrio M, Gabbrielli A, Scarpa A, Malleo G, Bassi C, Salvia R| | PubMed
  36. Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity Results from a Single-Center Surgical Series.
    Paiella S, Marchegiani G, Miotto M, Malpaga A, Impellizzeri H, Montagnini G, Pollini T, Nessi C, Butturini G, Capelli P, Posenato I, Scarpa A, D'Onofrio M, De Robertis R, Cingarlini S, Boninsegna L, Bassi C, Salvia R, Landoni L| | PubMed
  37. Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center.
    Paiella S, De Pastena M, Pollini T, Zancan G, Ciprani D, De Marchi G, Landoni L, Esposito A, Casetti L, Malleo G, Marchegiani G, Tuveri M, Marrano E, Maggino L, Secchettin E, Bonamini D, Bassi C, Salvia R| | PubMed
  38. Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies.
    Andrianello S, Marchegiani G, Malleo G, Pollini T, Bonamini D, Salvia R, Bassi C, Landoni L| | PubMed